Fulgent Genetics Inc
FLGT
Market Cap$632.9M
Close$
$36.45
79.1% upside
Current Fair Value
79.1% upsideUndervalued by 79.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $632.90 Million |
|---|---|
| Enterprise Value | $593.79 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.63 |
| Beta | 1.5 |
| Outstanding Shares | 30,098,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.85 |
|---|---|
| PEG | -32.72 |
| Price to Sales | 2.26 |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | 2.14 |
| Enterprise Value to EBIT | -7.53 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Fulgent Genetics Inc
429 employees
CEO: Ming Hsieh Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and...